{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:14:24Z","timestamp":1760044464362},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T00:00:00Z","timestamp":1400112000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0097022","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T16:44:18Z","timestamp":1400172258000},"page":"e97022","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hepatitis C Viremia Patterns in Incident Hepatitis C Infection and One Year Later in 150 Prospectively Tested Persons Who Inject Drugs"],"prefix":"10.1371","volume":"9","author":[{"given":"Marianne","family":"Alanko Blom\u00e9","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Bj\u00f6rkman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilma","family":"Molnegren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"H\u00f6glund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Widell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,5,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"K Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e69803","DOI":"10.1371\/journal.pone.0069803","article-title":"An apparent lack of epidemiologic association between hepatitis C virus knowledge and the prevalence of hepatitis C infection in a national survey in Egypt","volume":"8","author":"H Chemaitelly","year":"2013","journal-title":"PloS One"},{"key":"ref3","volume":"13","unstructured":"Duberg A, Janzon R, Back E, Ekdahl K, Blaxhult A (2008) The epidemiology of hepatitis C virus infection in Sweden. Euro Surveill <volume>13<\/volume> : pii = 18882"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Alberti A, Chemello L, Benvegnu L (1999) Natural history of hepatitis C. J Hepatol Suppl 1: 17\u201324.","DOI":"10.1016\/S0168-8278(99)80369-9"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"PK Nelson","year":"2011","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.jhep.2012.07.007","article-title":"Case definitions for acute hepatitis C virus infection: a systematic review","volume":"57","author":"B Hajarizadeh","year":"2012","journal-title":"J Hepatol"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Hatzakis A, Wait S, Bruix J, Buti M, Carballo M, <etal>et al<\/etal>. (2011) The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference. J Viral Hepat Suppl 1: 1\u201316.","DOI":"10.1111\/j.1365-2893.2011.01499.x"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijid.2008.06.011","article-title":"Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors","volume":"13","author":"ER Miller","year":"2009","journal-title":"Int J Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jcv.2007.09.013","article-title":"High prevalence of HCV in a cohort of injectors on methadone substitution treatment","volume":"41","author":"KC Lee","year":"2008","journal-title":"J Clin Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","article-title":"The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence","volume":"106","author":"KM Turner","year":"2011","journal-title":"Addiction"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1086\/605561","article-title":"Improving the diagnosis of acute hepatitis C virus infection with expanded viral load criteria","volume":"49","author":"BH McGovern","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(08)61116-2","article-title":"Acute hepatitis C","volume":"372","author":"A Maheshwari","year":"2008","journal-title":"Lancet"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s15010-004-3062-8","article-title":"Natural history of acute symptomatic hepatitis type C","volume":"32","author":"M Wawrzynowicz-Syczewska","year":"2004","journal-title":"Infection"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.2174\/138161208784746789","article-title":"Acute hepatitis C: clinical aspects, diagnosis, and outcome of acute HCV infection","volume":"14","author":"P Fabris","year":"2008","journal-title":"Curr Pharm Des"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jcv.2005.12.010","article-title":"Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection","volume":"36","author":"JH Aberle","year":"2006","journal-title":"J Clin Virol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2893.2005.00651.x","article-title":"Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies","volume":"13","author":"JM Micallef","year":"2006","journal-title":"J Viral Hepat"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bpg.2012.09.004","article-title":"The role of viral and host genetics in natural history and treatment of chronic HCV infection","volume":"26","author":"JS Doyle","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/hep.25575","article-title":"Spontaneous clearance of primary acute hepatitis C virus infection correlated with high initial viral RNA level and rapid HVR1 evolution","volume":"55","author":"L Liu","year":"2012","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/vim.2011.0052","article-title":"Hepatitis C virus spontaneous clearance: immunology and genetic variance","volume":"25","author":"M Amini","year":"2012","journal-title":"Viral Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1365-2893.2010.01429.x","article-title":"Ethnicity and route of HCV infection can influence the associations of HLA with viral clearance in an ethnically heterogeneous population","volume":"18","author":"BS de Almeida","year":"2011","journal-title":"J Viral Hepat"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1086\/592171","article-title":"Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe","volume":"198","author":"V Soriano","year":"2008","journal-title":"J Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1155\/2009\/912848","article-title":"Spontaneous clearance of hepatitis C after liver and renal transplantation","volume":"23","author":"CH Dale","year":"2009","journal-title":"Can J Gastroenterol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.transproceed.2012.07.074","article-title":"Spontaneous clearance of HCV in HIV-hepatitis C virus coinfected liver transplant patients: prospective study","volume":"44","author":"M Gutierrez-Moreno","year":"2012","journal-title":"Transplant Proc"},{"key":"ref24","first-page":"61","article-title":"Det tunga narkotikamissbrukets omfattning i Sverige 1998\/The extent of heavy drug abuse in Sweden 1998","volume":"3","author":"B Olsson","year":"2001","journal-title":"The MAX-project, Centralf\u00f6rbundet for alkohol- och narkotikaupplysning (CAN)"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2893.2010.01400.x","article-title":"Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program","volume":"18","author":"MA Blome","year":"2011","journal-title":"J Viral Hepat"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1099\/vir.0.82626-0","article-title":"Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma","volume":"88","author":"M Abdel-Hamid","year":"2007","journal-title":"J Gen Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-3148.2002.00359.x","article-title":"Detection of hepatitis C core antigen in serum or plasma as a marker of hepatitis C viraemia in the serological window-phase","volume":"12","author":"A Widell","year":"2002","journal-title":"Transfus Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1086\/605947","article-title":"Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection","volume":"200","author":"K Page","year":"2009","journal-title":"J Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1086\/423943","article-title":"Clearance of hepatitis C virus after newly acquired infection in injection drug users","volume":"190","author":"M Jauncey","year":"2004","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1086\/322795","article-title":"Is the prevalence of hepatitis C virus (HCV) RNA in anti-HCV-positive injection drug users positively correlated with age?","volume":"184","author":"C Mathei","year":"2001","journal-title":"J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/344314","article-title":"A genetic analysis of hepatitis C virus transmission between injection drug users","volume":"186","author":"A Cochrane","year":"2002","journal-title":"J Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/00365540050165875","article-title":"Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe\/needle exchange program","volume":"32","author":"AS Mansson","year":"2000","journal-title":"Scand J Infect Dis"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Des Jarlais DC, Perlis T, Arasteh K, Torian LV, Hagan H, <etal>et al<\/etal>. (2005) Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990\u20132001. AIDS Suppl 3: S20\u20135.","DOI":"10.1097\/01.aids.0000192066.86410.8c"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/cis921","article-title":"Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection","volume":"56","author":"K Page","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jhep.2009.05.027","article-title":"Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam","volume":"51","author":"TJ van de Laar","year":"2009","journal-title":"J Hepatol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2013.03.008","article-title":"Hepatitis C virus reinfection among prisoners with sustained virological response after treatment for chronic hepatitis C","volume":"59","author":"A Marco","year":"2013","journal-title":"J Hepatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000049487","article-title":"Treatment of chronic hepatitis C in injecting drug users: 5 years&apos; follow-up","volume":"8","author":"O Dalgard","year":"2002","journal-title":"Eur Addict Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2893.2006.00812.x","article-title":"High incidence of hepatitis C virus reinfection within a cohort of injecting drug users","volume":"14","author":"JM Micallef","year":"2007","journal-title":"J Viral Hepat"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0097022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T15:00:59Z","timestamp":1540220459000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0097022"}},"subtitle":[],"editor":[{"given":"Birke","family":"Bartosch","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,15]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0097022","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,15]]}}}